GB Patent

GB1308106A — Phenoxyhydroxypropylamines and their preparation

Assigned to Hassle AB · Expires 1973-02-28 · 53y expired

What this patent protects

1308106 Substituted phenoxy-hydroxy propylamines HASSLE AB 19 April 1971 [18 Feb 1970] 21994/71 Heading C2C Novel compounds of the Formula IV wherein R<SP>1</SP> is isopropyl or t-butyl, A is a straight or branched C 1-4 alkylene chain and Z is -OR<SP>2</SP&…

USPTO Abstract

1308106 Substituted phenoxy-hydroxy propylamines HASSLE AB 19 April 1971 [18 Feb 1970] 21994/71 Heading C2C Novel compounds of the Formula IV wherein R<SP>1</SP> is isopropyl or t-butyl, A is a straight or branched C 1-4 alkylene chain and Z is -OR<SP>2</SP>, -SO 2 R<SP>2</SP>, -SOR<SP>2</SP>, -SR<SP>2</SP>, NR 3 -COR<SP>2</SP>, NR 3 SO 2 R<SP>2</SP> or NR<SP>3</SP>COOR<SP>2</SP> wherein R<SP>2</SP> is straight or branched C 1-3 alkyl and R<SP>3</SP> is hydrogen or a straight or branched alkyl radioal and pharmaceutically acceptable acid addition salts thereof may be prepared by (i) reacting a compound V wherein X is an unsubstituted ethylene oxide ring or -CHOHCH 2 -halogen with a compound R<SP>1</SP>NHCONHR<SP>1</SP> or R<SP>1</SP>NH 2 ; (ii) reductively alkylating IV wherein R<SP>1</SP> is H with acetone to produce IV, R<SP>1</SP> = iPr; (iii) alkylating IV R<SP>1</SP> = H with Hal-CH(CH 3 ) 2 where Hal is a halogen atom; (iv) hydrolysing a compound wherein R<SP>4</SP> is a hydrolytioally removable group; (v) hydrolysing a compound with strong acid or strong alkali (vi) hydrolysing or pyrolysing a compound wherein R<SP>6</SP> and R<SP>6</SP> are hydrogen, C 1-4 alkyl, aralkyl or aryl; (vii) hydrolysing or hydrogenolysing a compound wherein R<SP>7</SP> is an amine protecting group; (viii) reacting XCH 2 NHR<SP>1</SP> or XCH 2 NR<SP>1</SP>R<SP>7</SP> with a phenolate (ix) reducing a compound wherein B is -CHOHCO- or -COOH 2 -, (x) hydrolysing a compound wherein R<SP>8</SP> is C 1-4 alkyl, aralkyl or aryl or, (xi) hydrogenolysing a compound wherein Y means the benzene ring is substituted with 1 to 4 halogen atoms. The intermediates V may be prepared by reacting an appropriately para-substituted phenol with chlorohydrin followed in the case where X is CHOHCH 2 Cl, by treatment with hydrochloric acid. 2 - Hydroxy - 3 - [p - (methoxyethyl) - phenoxy]- N - isopropyl propionamide may be prepared by reacting the free acid with isopropylamine, the free acid in turn being prepared by condensingp-methoxy ethyl phenol with 2-hydroxy- 3-chloropropionic acid. A 1 - isopropylamino - 3 - [bromo - p - (#- methoxyethyl) - phenoxy] - propanol - 2 may be prepared by brominating p-(#-methoxyethyl)- phenyl to give a brcmo-p-(#-methoxyethyl)- phenol which is reacted with chlorohydrin followed by isopropylamine to yield the required compound. Pharmaceutical compositions of the compounds IV may be used for treatment of heart diseases and vascular diseases when administered orally, parenterally or rectally with excipients or diluents.

Drugs covered by this patent

Patent Metadata

Patent number
GB1308106A
Jurisdiction
GB
Classification
Expires
1973-02-28
Drug substance claim
No
Drug product claim
No
Assignee
Hassle AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.